Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia
Clinical trial NCT05184764 · COMPLETED
Trial details
- NCT number
- NCT05184764
- Sponsor
- Armata Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-26
- Primary completion
- 2024-11-07
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.